LINC01343

Across TCGA pan-cancer cohorts, LINC01343 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01343 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC01343 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01343 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

MESO, ESCA, and UCEC are the cancer types where LINC01343 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Median	IV	0.150	0.464	.001	96	view →
ESCA	OS	Median	III,IV	0.703	0.466	.013	63	view →
UCEC	OS	Tertile	All	0.741	0.888	<.001	42	view →
THCA	DFS	Quartile	II,III,IV	1.000	0.523	.011	35	view →
LGG	OS	Median	All	0.745	0.859	<.001	35	view →
CHOL	DFS	Tertile	All	0.089	0.521	.016	27	view →
HNSC	OS	Tertile	All	0.581	0.175	.004	25	view →
SKCM	OS	Tertile	All	0.238	0.385	.001	20	view →
KIRP	OS	Tertile	III,IV	1.000	0.327	.030	18	view →
READ	OS	Tertile	II,III,IV	0.198	0.692	.003	18	view →
UVM	DFS	Quartile	All	1.000	0.631	.015	16	view →
BRCA	OS	Quartile	All	0.529	0.585	.017	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01343–MESO (DFS)

Open the MESO breakdown →